These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 inhibitors provide a platform for new antivirals. Kottur J, White KM, Rodriguez ML, Rechkoblit O, Quintana-Feliciano R, Nayar A, García-Sastre A, Aggarwal AK. PLoS Pathog; 2023 Jul; 19(7):e1011546. PubMed ID: 37523415 [Abstract] [Full Text] [Related]
33. Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA. Ferron F, Subissi L, Silveira De Morais AT, Le NTT, Sevajol M, Gluais L, Decroly E, Vonrhein C, Bricogne G, Canard B, Imbert I. Proc Natl Acad Sci U S A; 2018 Jan 09; 115(2):E162-E171. PubMed ID: 29279395 [Abstract] [Full Text] [Related]
36. Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis. Wang Y, Sun Y, Wu A, Xu S, Pan R, Zeng C, Jin X, Ge X, Shi Z, Ahola T, Chen Y, Guo D. J Virol; 2015 Aug 09; 89(16):8416-27. PubMed ID: 26041293 [Abstract] [Full Text] [Related]
40. Live attenuated coronavirus vaccines deficient in N7-Methyltransferase activity induce both humoral and cellular immune responses in mice. Zhang Z, Liu Q, Sun Y, Li J, Liu J, Pan R, Cao L, Chen X, Li Y, Zhang Y, Xu K, Guo D, Zhou L, Lan K, Chen Y. Emerg Microbes Infect; 2021 Dec 09; 10(1):1626-1637. PubMed ID: 34365904 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]